179 related articles for article (PubMed ID: 32781450)
1. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.
Wang S; Wang J; Wang N
Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children.
Zhao Q; Hao Q
Int Ophthalmol; 2021 Mar; 41(3):1011-1017. PubMed ID: 33205372
[TBL] [Abstract][Full Text] [Related]
3. Myopia prevention and control in children: a systematic review and network meta-analysis.
Zhang G; Jiang J; Qu C
Eye (Lond); 2023 Nov; 37(16):3461-3469. PubMed ID: 37106147
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks of orthokeratology treatment: a systematic review and meta-analysis.
Sartor L; Hunter DS; Vo ML; Samarawickrama C
Int Ophthalmol; 2024 Jun; 44(1):239. PubMed ID: 38904856
[TBL] [Abstract][Full Text] [Related]
5. Effect of COVID-19 home confinement on the efficacy of orthokeratology, 0.01% atropine and combined treatment.
Xu S; Jiang J; Yu M; Gao J; Wang M; Kuang L; Hu Y; Kee CS; Yang X; He M
Acta Ophthalmol; 2024 Jun; 102(4):e620-e627. PubMed ID: 37983888
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of orthokeratology lenses with smaller back optic zone diameter in myopia control. A meta-analysis.
Zhou Y; Li H; Hao J; Pan W; Yang Z; Lan W
Ophthalmic Physiol Opt; 2024 Jun; ():. PubMed ID: 38881171
[TBL] [Abstract][Full Text] [Related]
7. Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study.
Chia A; Ngo C; Choudry N; Yamakawa Y; Tan D
Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):370-376. PubMed ID: 37523428
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the reports of low-concentration atropine in controlling myopia in children.
Zhang M; Qiu W; An M; Sun Y; Zhang Z; Yu C
J Fr Ophtalmol; 2023 Mar; 46(3):239-248. PubMed ID: 36797093
[TBL] [Abstract][Full Text] [Related]
9. The optimal atropine concentration for myopia control in Chinese children: a systematic review and network Meta-analysis.
Wang XY; Deng HW; Yang J; Zhu XM; Xiang FL; Tu J; Huang MX; Wang Y; Gan JH; Yang WH
Int J Ophthalmol; 2024; 17(6):1128-1137. PubMed ID: 38895669
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of 0.03% Atropine Eye Drops in Controlling Myopia Progression: A One-Year Prospective Clinical Study.
Simonaviciute D; Grzybowski A; Gelzinis A; Zemaitiene R
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892929
[No Abstract] [Full Text] [Related]
11. A Meta-Analysis Assessing Change in Pupillary Diameter, Accommodative Amplitude, and Efficacy of Atropine for Myopia Control.
Tran HDM; Sankaridurg P; Naduvilath T; Ha TTX; Tran TD; Jong M; Coroneo M; Tran YH
Asia Pac J Ophthalmol (Phila); 2021 Aug; 10(5):450-460. PubMed ID: 34456234
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of randomized controlled trials evaluating the effectiveness and safety of the repeated low-level red light therapy in slowing the progression of myopia in children and adolescents.
Deng B; Zhou M; Kong X; Luo L; Lv H
Indian J Ophthalmol; 2024 Feb; 72(Suppl 2):S203-S210. PubMed ID: 38099371
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Low-Dose Atropine on Myopia Prevention in Premyopic Children: Systematic Review and Meta-Analysis.
Lee SH; Tseng BY; Wang JH; Chiu CJ
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592670
[No Abstract] [Full Text] [Related]
14. Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia.
Pugazhendhi S; Ambati B; Hunter AA
Clin Ophthalmol; 2020; 14():853-873. PubMed ID: 32256044
[TBL] [Abstract][Full Text] [Related]
15. Identifying and Exploring the Impact Factors for Intraocular Pressure Prediction in Myopic Children with Atropine Control Utilizing Multivariate Adaptive Regression Splines.
Wu TE; Chen JW; Liu TC; Yu CH; Jhou MJ; Lu CJ
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38276247
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Progression in Myopia: A Systematic Review.
Vagge A; Ferro Desideri L; Nucci P; Serafino M; Giannaccare G; Traverso CE
Diseases; 2018 Sep; 6(4):. PubMed ID: 30274355
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Gao C; Wan S; Zhang Y; Han J
Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children.
Tsai WS; Wang JH; Chiu CJ
Sci Rep; 2020 Aug; 10(1):14176. PubMed ID: 32843658
[TBL] [Abstract][Full Text] [Related]
19. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
[TBL] [Abstract][Full Text] [Related]
20. Slowing the Progression of Myopia in Children with the MiSight Contact Lens: A Narrative Review of the Evidence.
Ruiz-Pomeda A; Villa-Collar C
Ophthalmol Ther; 2020 Dec; 9(4):783-795. PubMed ID: 32915454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
